Marriage Counselors in Clarkston, MI Accepting Medicare

7 Marriage Counselors found. Showing 1 - 7

Rachel Blanchette Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 6548 Town Center Dr Ste D, Clarkston, MI 48346 Phone: 810-300-0770

Dr. Stanley B. Garwood Jr., MSW LMSW Marriage & Family Therapist Medicare: Accepting Medicare Assignments Practice Location: 9340 Dixie Hwy., Clarkston, MI 48348 Phone: 248-625-3123

Monica Lynn Munir, LLMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 7300 Dixie Hwy Ste 300, Clarkston, MI 48346 Phone: 734-560-8200

Mrs. Molly B Schaar, LLMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5900 S Main St Ste 100, Clarkston, MI 48346 Phone: 248-843-2160

Emily Short, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5900 S Main St, Clarkston, MI 48346 Phone: 810-869-3931

Mrs. Wendy Sparks, LLMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5900 S Main St Ste 100, Clarkston, MI 48346 Phone: 947-888-9432

Dana A. Behlmer Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 6195 Middle Lake Rd, Clarkston, MI 48346 Phone: 775-323-4242

News Archive

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

ZirMed®, a national provider of revenue cycle management services for healthcare practices, and leading integrated healthcare technology company Raintree Systems Inc. today announced a working partnership to jointly market their combined solutions to current and prospective customers. As a result of the partnership, ZirMed's flagship revenue cycle management platform will be integrated with Raintree's practice management and Electronic Medical Records (EMR) products, giving users state-of-the-art technology with which to better manage their daily operations.

Deloitte Consulting offers new sales strategy for pharmaceutical companies

Pharmaceutical companies face a fundamental decision about the best way to sell their products. Even if they could find a way to make the current sales model work, pharma companies still face sky-high commercial costs. So, the question is, should pharma companies stick with their traditional sales approach or blow it up and try something new?

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Neuralstem, Inc. announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

Senate Finance Committee weighs proposal to tax employer health benefits, other plans to pay for health reform

The Senate Finance Committee on Tuesday heard arguments for taxing employer-sponsored health care benefits as a means for funding a comprehensive health care overhaul, the Wall Street Journal reports.

Read more Medical News

› Verified 6 days ago